TEVA PHARMACEUTICAL FINANCE NETHERLANDS III B.V., as Issuer, TEVA PHARMACEUTICAL INDUSTRIES LIMITED, as Guarantor, and THE BANK OF NEW YORK MELLON, as Trustee FOURTH SUPPLEMENTAL SENIOR INDENTURE Dated as of March 9, 2023 to the Senior Indenture dated...Fourth Supplemental Senior Indenture • March 9th, 2023 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
FOURTH SUPPLEMENTAL SENIOR INDENTURE, dated as of March 9, 2023, by and among Teva Pharmaceutical Finance Netherlands III B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid), incorporated under Dutch law (the “Issuer”), Teva Pharmaceutical Industries Limited, a corporation incorporated under the laws of Israel (the “Guarantor”) and The Bank of New York Mellon, a New York banking corporation, as trustee (the “Trustee”)
FOURTH SUPPLEMENTAL SENIOR INDENTURE between REINSURANCE GROUP OF AMERICA, INCORPORATED and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee Dated as of May 27, 2011 5.000% Senior Notes due 2021Fourth Supplemental Senior Indenture • May 31st, 2011 • Reinsurance Group of America Inc • Accident & health insurance • New York
FOURTH SUPPLEMENTAL SENIOR INDENTURE, dated as of May 27, 2011 (this “Fourth Supplemental Indenture”), between REINSURANCE GROUP OF AMERICA, INCORPORATED, a Missouri corporation (the “Company”), having its principal executive office at 1370 Timberlake Manor Parkway, Chesterfield, Missouri 63017-6039 and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., a national banking association, as successor trustee to The Bank of New York (the “Trustee”), having its corporate trust office at 2 North LaSalle, Suite 1020, Chicago, Illinois 60602, supplementing the Senior Indenture, dated as of December 19, 2001, between the Company and the Trustee (the “Base Indenture”, together with the this Fourth Supplemental Indenture, the “Indenture”).
